Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 7

Results: 14

Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab′)<sub>2</sub> fragment of anti-CD16 antibody.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1053, doi. 10.1007/s00262-007-0437-6

By:

Jewett, Anahid;
Teruel, Antonia;
Romero, Marcela;
Head, Christian;
Cacalano, Nicholas

Publication type:

Article

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 977, doi. 10.1007/s00262-007-0428-7

By:

Harrop, Richard;
Drury, Noel;
Shingler, William;
Chikoti, Priscilla;
Redchenko, Irina;
Carroll, Miles W.;
Kingsman, Susan M.;
Naylor, Stuart;
Griffiths, Richard;
Steven, Neil;
Hawkins, Robert E.

Publication type:

Article

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 951, doi. 10.1007/s00262-007-0425-x

By:

Mulligan, Jennifer K.;
Lathers, Deanne M. R.;
Young, M. Rita I.

Publication type:

Article

In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1067, doi. 10.1007/s00262-007-0438-5

By:

Gravekamp, Claudia;
Leal, Belinda;
Denny, Ashley;
Bahar, Rumana;
Lampkin, Shellye;
Castro, Francisco;
Kim, Sun;
Moore, Dan;
Reddick, Robert

Publication type:

Article

CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 963, doi. 10.1007/s00262-007-0427-8

By:

Xiaorong Lin;
Gudgeon, Nancy H.;
Hui, Edwin P.;
Hui Jia;
Xue Qun;
Taylor, Graham S.;
Barnardo, Martin C. N. M.;
Lin, C. Kit;
Rickinson, Alan B.;
Chan, Anthony T. C.

Publication type:

Article

Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1029, doi. 10.1007/s00262-007-0434-9

By:

Li-HuaXie;
Fion Sin;
Samuel Cheng;
Ying-Kit Cheung;
Kin-Tak Chan;
Yi Xie;
Yong Xie

Publication type:

Article

Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1079, doi. 10.1007/s00262-007-0439-4

By:

Wondimu, Assefa;
Zhang, Tianqian;
Kieber-Emmons, Thomas;
Gimotty, Phyllis;
Sproesser, Katrin;
Somasundaram, Rajasekharan;
Ferrone, Soldano;
Tsao, Chun-Yen;
Herlyn, Dorothee

Publication type:

Article

Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1039, doi. 10.1007/s00262-007-0435-8

By:

Hersey, P.;
Halliday, G. M.;
Farrelly, M. L.;
DeSilva, C.;
Lett, M.;
Menzies, S. W.

Publication type:

Article

Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 997, doi. 10.1007/s00262-007-0430-0

By:

Gu, Tao;
Kilinc, Mehmet O.;
Egilmez, Nejat K.

Publication type:

Article

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 987, doi. 10.1007/s00262-007-0429-6

By:

Siva, A.;
Xin, H.;
Qin, F.;
Oltean, D.;
Bowdish, K. S.;
Kretz-Rommel, A.

Publication type:

Article

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1007, doi. 10.1007/s00262-007-0431-z

By:

Yamamoto, Nobuto;
Suyama, Hirofumi;
Nakazato, Hiroaki;
Yamamoto, Nobuyuki;
Koga, Yoshihiko

Publication type:

Article

A33 antigen displays persistent surface expression.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1017, doi. 10.1007/s00262-007-0433-x

By:

Ackerman, Margaret E.;
Chalouni, Cecile;
Schmidt, Michael M.;
Raman, Vivek V.;
Ritter, Gerd;
Old, Lloyd J.;
Mellman, Ira;
Wittrup, K. Dane

Publication type:

Article

Local therapy of cancer with free IL-2.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 931, doi. 10.1007/s00262-008-0455-z

By:

Otter, Willem Den;
Jacobs, John J. L.;
Battermann, Jan J.;
Hordijk, Gerrit Jan;
Krastev, Zachary;
Moiseeva, Ekaterina V.;
Stewart, Rachel J. E.;
Ziekman, Paul G. P. M.;
Koten, Jan Willem

Publication type:

Article

Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 7, p. 1091, doi. 10.1007/s00262-007-0446-5

By:

Ya-Wen Hsiao;
Kuang-Wen Liao;
Tien-Fu Chung;
Chen-Hsuan Liu;
Chia-Da Hsu;
Rea-Min Chu

Publication type:

Article